Latest progressive multifocal leukoencephalopathy Stories
Natalizumab Was Well-Tolerated Under Double the Standard Dose Schedule NEW YORK, April 20, 2015 /PRNewswire-USNewswire/ -- Extending the dose of an infusion medication for multiple
The JC polyomavirus is clearly opportunistic. It infects half the population but lethally destroys brain tissue only in immunocompromised patients — and it may be outright sneaky, too.
The drug natalizumab is effective for treating multiple sclerosis (MS), but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML).
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.